L-738167

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameL-738167
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibrinogen receptors inhibitorsPlatelet aggregation inhibitorsIntegrin alpha-IIb/beta-3 antagonists
TargetsFibrinogen receptorsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A